Reading Time: 2 minutes A new national survey about depression has just been launched. The MND Association is supporting this new priority setting partnership as we would like to know what
Reading Time: 4 minutes The top-line results from the Cytokinetics Inc Phase IIb clinical trial of Tirasemtiv were announced last week. Following this announcement, detailed results were then presented
Reading Time: 2 minutes A lot has been happening in terms of research policy at the moment, from the announcement of the European adaptive licensing pilot to the Government’s Early Access to
Reading Time: 4 minutes The day finally arrived on 11 April 2014 for our biannual Biomedical Research Advisory Panel (BRAP) Meeting. This important date in our research calendar is
Reading Time: 4 minutes Dr Jakub Scaber from the University of Oxford is our newest Medical Research Council (MRC)/ MND Association Lady Edith Wolfson Clinical Research Fellow. He is investigating
Reading Time: 4 minutes Last month the UK Government’s Department of Health announced an Early Access to Medicines Scheme. But, what is this new scheme? and what does it
Reading Time: 3 minutes Prof Vladimir Buchman (Cardiff University)’s research was selected as one of the best research studies, as decided by the journal editors, published in the Journal
Reading Time: 4 minutes MND Association-funded researcher, Prof Linda Greensmith, based at University College London, together with her collaborator Dr Ivo Lieberam from Kings College London, have introduced stem
Reading Time: 4 minutes Following on from our ’year of hope’ appeal last month an international team of researchers, including two funded by the MND Association, have identified mutations
Reading Time: 3 minutes On 3 March 2014, researchers based at the University of Edinburgh published a research paper that extends our understanding of the childhood disease – Spinal